> top > docs > PMC:7205724 > spans > 21921-22331 > annotations

PMC:7205724 / 21921-22331 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
760 374-382 Species denotes children Tax:9606
761 58-63 Species denotes human Tax:9606
762 0-11 Chemical denotes Tocilizumab MESH:C502936
763 131-150 Disease denotes autoimmune diseases MESH:D001327
764 194-214 Disease denotes rheumatoid arthritis MESH:D001172
765 216-236 Disease denotes giant cell arteritis MESH:D013700
766 238-281 Disease denotes polyarticular juvenile idiopathic arthritis MESH:D001171
767 287-327 Disease denotes systematic juvenile idiopathic arthritis MESH:D001171

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T160 77-85 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T161 167-175 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T162 222-226 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T165 131-150 Disease denotes autoimmune diseases http://purl.obolibrary.org/obo/MONDO_0007179
T166 194-214 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T167 205-214 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T168 216-236 Disease denotes giant cell arteritis http://purl.obolibrary.org/obo/MONDO_0008538
T169 227-236 Disease denotes arteritis http://purl.obolibrary.org/obo/MONDO_0043494
T170 238-281 Disease denotes polyarticular juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0018456
T171 252-281 Disease denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0011429
T172 272-281 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T173 298-327 Disease denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0011429
T174 318-327 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T261 41-42 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T262 43-52 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humanized
T263 58-63 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T264 222-226 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T100 142-150 http://purl.obolibrary.org/obo/OGMS_0000031 denotes diseases
T101 222-226 http://purl.obolibrary.org/obo/CL_0000000 denotes cell

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T216 58-63 Species denotes human NCBItxid:9606

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T179 0-328 Sentence denotes Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis.
T180 329-410 Sentence denotes It is safe and effective for both adults and children two years of age and older.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
762 0-11 Chemical denotes Tocilizumab MESH:C502936
761 58-63 Species denotes human Tax:9606
763 131-150 Disease denotes autoimmune diseases MESH:D001327
764 194-214 Disease denotes rheumatoid arthritis MESH:D001172
765 216-236 Disease denotes giant cell arteritis MESH:D013700
766 238-281 Disease denotes polyarticular juvenile idiopathic arthritis MESH:D001171
767 287-327 Disease denotes systematic juvenile idiopathic arthritis MESH:D001171
760 374-382 Species denotes children Tax:9606

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T2117 64-67 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T86439 0-11 NNP denotes Tocilizumab
T21494 11-12 -COMMA- denotes ,
T50157 13-17 RB denotes also
T26283 18-23 VBN denotes known
T43571 24-26 IN denotes as
T44785 27-36 NN denotes atlizumab
T96810 36-37 -COMMA- denotes ,
T58761 38-40 VBZ denotes is
T56416 41-42 DT denotes a
T79548 43-52 JJ denotes humanized
T29074 53-63 JJ denotes anti-human
T88685 64-67 NN denotes IL6
T26777 68-76 NN denotes receptor
T24185 77-85 NN denotes antibody
T17221 86-94 VBN denotes approved
T32471 95-97 IN denotes by
T53882 98-101 NNP denotes FDA
T24580 102-105 IN denotes for
T33924 106-113 JJ denotes several
T90119 114-126 JJ denotes inflammatory
T59846 127-130 CC denotes and
T31666 131-141 JJ denotes autoimmune
T46803 142-150 NNS denotes diseases
T80969 151-157 JJ denotes severe
T13017 157-158 -COMMA- denotes ,
T79015 159-163 JJ denotes such
T43255 164-166 IN denotes as
T47553 167-175 NN denotes cytokine
T34694 176-183 NN denotes release
T36705 184-192 NN denotes syndrome
T68837 192-193 -COMMA- denotes ,
T30269 194-204 JJ denotes rheumatoid
T54700 205-214 NN denotes arthritis
T81658 214-215 -COMMA- denotes ,
T84650 216-221 JJ denotes giant
T11095 222-226 NN denotes cell
T15987 227-236 NN denotes arteritis
T88887 236-237 -COMMA- denotes ,
T31599 238-251 JJ denotes polyarticular
T93322 252-260 JJ denotes juvenile
T49595 261-271 JJ denotes idiopathic
T62141 272-281 NN denotes arthritis
T76737 281-282 -COMMA- denotes ,
T30470 283-286 CC denotes and
T13999 287-297 JJ denotes systematic
T88238 298-306 JJ denotes juvenile
T89892 307-317 JJ denotes idiopathic
T97598 318-327 NN denotes arthritis
T25454 329-331 PRP denotes It
T28665 332-334 VBZ denotes is
T15312 335-339 JJ denotes safe
T18121 340-343 CC denotes and
T2467 344-353 JJ denotes effective
T39207 354-357 IN denotes for
T89869 358-362 DT denotes both
T32842 363-369 NNS denotes adults
T38357 370-373 CC denotes and
T13891 374-382 NNS denotes children
T61388 383-386 CD denotes two
T66576 387-392 NNS denotes years
T46590 393-395 IN denotes of
T15404 396-399 NN denotes age
T19164 400-403 CC denotes and
T99851 404-409 JJR denotes older
R83125 T86439 T21494 arg1Of Tocilizumab,","
R13146 T26283 T50157 arg1Of known,also
R82868 T86439 T26283 arg2Of Tocilizumab,known
R76811 T26283 T43571 arg1Of known,as
R6462 T44785 T43571 arg2Of atlizumab,as
R65301 T58761 T96810 arg1Of is,","
R91756 T86439 T58761 arg1Of Tocilizumab,is
R48338 T24185 T58761 arg2Of antibody,is
R19276 T24185 T56416 arg1Of antibody,a
R24087 T24185 T79548 arg1Of antibody,humanized
R65895 T24185 T29074 arg1Of antibody,anti-human
R2263 T24185 T88685 arg1Of antibody,IL6
R21524 T24185 T26777 arg1Of antibody,receptor
R18021 T53882 T17221 arg1Of FDA,approved
R77534 T24185 T17221 arg2Of antibody,approved
R58214 T53882 T32471 arg2Of FDA,by
R27887 T17221 T24580 arg1Of approved,for
R20734 T80969 T24580 arg2Of severe,for
R13465 T46803 T33924 arg1Of diseases,several
R86212 T46803 T90119 arg1Of diseases,inflammatory
R60939 T90119 T59846 arg1Of inflammatory,and
R4444 T31666 T59846 arg2Of autoimmune,and
R87485 T46803 T31666 arg1Of diseases,autoimmune
R90538 T46803 T80969 arg1Of diseases,severe
R97819 T17221 T13017 arg1Of approved,","
R24341 T43255 T79015 arg1Of as,such
R92610 T24185 T43255 arg1Of antibody,as
R33248 T30470 T43255 arg2Of and,as
R45357 T36705 T47553 arg1Of syndrome,cytokine
R21959 T36705 T34694 arg1Of syndrome,release
R41949 T36705 T68837 arg1Of syndrome,","
R19260 T54700 T68837 arg2Of arthritis,","
R59437 T54700 T30269 arg1Of arthritis,rheumatoid
R79844 T68837 T81658 arg1Of ",",","
R96846 T15987 T81658 arg2Of arteritis,","
R42046 T15987 T84650 arg1Of arteritis,giant
R12475 T15987 T11095 arg1Of arteritis,cell
R20864 T81658 T88887 arg1Of ",",","
R12170 T62141 T88887 arg2Of arthritis,","
R2759 T62141 T31599 arg1Of arthritis,polyarticular
R56313 T62141 T93322 arg1Of arthritis,juvenile
R57671 T62141 T49595 arg1Of arthritis,idiopathic
R19638 T30470 T76737 arg1Of and,","
R50655 T88887 T30470 arg1Of ",",and
R47508 T97598 T30470 arg2Of arthritis,and
R2665 T97598 T13999 arg1Of arthritis,systematic
R42821 T97598 T88238 arg1Of arthritis,juvenile
R23852 T97598 T89892 arg1Of arthritis,idiopathic
R65763 T25454 T28665 arg1Of It,is
R63345 T18121 T28665 arg2Of and,is
R33385 T25454 T15312 arg1Of It,safe
R71645 T15312 T18121 arg1Of safe,and
R79824 T2467 T18121 arg2Of effective,and
R87665 T25454 T2467 arg1Of It,effective
R86934 T18121 T39207 arg1Of and,for
R81304 T38357 T39207 arg2Of and,for
R77360 T38357 T89869 arg1Of and,both
R78333 T32842 T38357 arg1Of adults,and
R34196 T13891 T38357 arg2Of children,and
R37501 T66576 T61388 arg1Of years,two
R85448 T38357 T66576 arg1Of and,years
R80686 T66576 T46590 arg1Of years,of
R92175 T15404 T46590 arg2Of age,of
R77190 T66576 T19164 arg1Of years,and
R33791 T99851 T19164 arg2Of older,and
R24950 T38357 T99851 arg1Of and,older

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T160 77-85 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T161 167-175 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T162 222-226 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T160 131-150 Disease denotes autoimmune diseases http://purl.obolibrary.org/obo/MONDO_0007179
T161 194-214 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T162 216-236 Disease denotes giant cell arteritis http://purl.obolibrary.org/obo/MONDO_0008538
T163 238-281 Disease denotes polyarticular juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0018456
T164 298-327 Disease denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0011429

LitCovid-sample-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T9 131-150 Phenotype denotes autoimmune diseases http://purl.obolibrary.org/obo/HP_0002960
T10 194-214 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T11 227-236 Phenotype denotes arteritis http://purl.obolibrary.org/obo/HP_0012089
T12 252-281 Phenotype denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/HP_0005681
T13 298-327 Phenotype denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/HP_0005681

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T179 0-328 Sentence denotes Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis.
T180 329-410 Sentence denotes It is safe and effective for both adults and children two years of age and older.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T9 131-150 Phenotype denotes autoimmune diseases http://purl.obolibrary.org/obo/HP_0002960
T10 167-192 Phenotype denotes cytokine release syndrome http://purl.obolibrary.org/obo/HP_0033041
T11 194-214 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T12 227-236 Phenotype denotes arteritis http://purl.obolibrary.org/obo/HP_0012089
T13 252-281 Phenotype denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/HP_0005681
T14 298-327 Phenotype denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/HP_0005681